Global Left Ventricular Function After Acute Myocardial Infarction: Treatment With the Angiotensin 2-Receptor Blocker Irbesartan.
Phase of Trial: Phase IV
Latest Information Update: 15 May 2018
At a glance
- Drugs Irbesartan (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms GLOBAL
- 31 Aug 2018 Biomarkers information updated
- 02 May 2018 Status changed from suspended to completed.
- 15 Aug 2011 Additional lead investigator (Kenneth Egstrup) added as reported by ClinicalTrials.gov.